IRIS UniCatt

Leone, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.478
EU - Europa 12.293
AS - Asia 8.741
SA - Sud America 1.414
AF - Africa 235
OC - Oceania 191
Continente sconosciuto - Info sul continente non disponibili 12
Totale 37.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.114
DE - Germania 5.230
SG - Singapore 3.575
CN - Cina 2.815
SE - Svezia 1.602
BR - Brasile 1.144
UA - Ucraina 1.089
IT - Italia 1.046
FR - Francia 814
VN - Vietnam 642
GB - Regno Unito 640
PL - Polonia 493
IE - Irlanda 392
IN - India 356
FI - Finlandia 271
ID - Indonesia 250
TR - Turchia 199
CA - Canada 190
JP - Giappone 189
RU - Federazione Russa 188
AU - Australia 163
BD - Bangladesh 135
HK - Hong Kong 117
NL - Olanda 107
AR - Argentina 105
MX - Messico 100
IQ - Iraq 79
ES - Italia 69
ZA - Sudafrica 55
CI - Costa d'Avorio 51
BE - Belgio 49
IR - Iran 36
PK - Pakistan 36
VE - Venezuela 36
EC - Ecuador 34
SA - Arabia Saudita 34
CH - Svizzera 31
AT - Austria 30
CO - Colombia 29
NO - Norvegia 28
EG - Egitto 27
NZ - Nuova Zelanda 27
RO - Romania 26
IL - Israele 25
KR - Corea 25
UZ - Uzbekistan 25
JO - Giordania 23
MA - Marocco 23
AE - Emirati Arabi Uniti 21
CL - Cile 20
PH - Filippine 20
LT - Lituania 19
PY - Paraguay 19
BG - Bulgaria 18
KE - Kenya 18
GR - Grecia 17
HU - Ungheria 16
MY - Malesia 16
PT - Portogallo 16
CZ - Repubblica Ceca 15
DZ - Algeria 15
CR - Costa Rica 14
AZ - Azerbaigian 13
TH - Thailandia 13
SK - Slovacchia (Repubblica Slovacca) 12
JM - Giamaica 11
NP - Nepal 11
OM - Oman 11
UY - Uruguay 11
ET - Etiopia 10
KZ - Kazakistan 10
DO - Repubblica Dominicana 9
HN - Honduras 9
HR - Croazia 9
LB - Libano 9
LV - Lettonia 9
PE - Perù 9
RS - Serbia 9
TN - Tunisia 9
GE - Georgia 8
AL - Albania 7
BO - Bolivia 7
EU - Europa 7
AM - Armenia 6
DK - Danimarca 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
MK - Macedonia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BZ - Belize 4
GH - Ghana 4
KG - Kirghizistan 4
NI - Nicaragua 4
SI - Slovenia 4
SN - Senegal 4
SV - El Salvador 4
Totale 37.292
Salva come PNG Salva come JPEG
Città #
Singapore 1.936
Chandler 1.602
Ashburn 1.485
San Jose 1.035
Jacksonville 697
Beijing 503
Nanjing 453
San Mateo 450
Dearborn 445
Warsaw 443
Dublin 378
Ann Arbor 348
Nürnberg 329
Houston 300
Los Angeles 300
Woodbridge 279
New York 272
Wilmington 256
Milan 228
Jakarta 219
Munich 208
Seattle 208
Lauterbourg 189
Hangzhou 187
Ho Chi Minh City 187
Hefei 182
Nanchang 181
Hanoi 177
Redwood City 153
Tokyo 152
Lawrence 149
Boston 147
Izmir 136
Fairfield 135
Dallas 131
Bremen 130
Frankfurt am Main 130
Buffalo 124
Marseille 121
Moscow 112
Rome 102
Chicago 100
Hong Kong 100
Kunming 100
São Paulo 100
Lancaster 99
Cattolica 84
Santa Clara 84
Shenyang 80
Guangzhou 74
Zhengzhou 74
Orem 73
Tianjin 67
University Park 67
Hebei 61
Leawood 59
Princeton 58
London 57
The Dalles 57
Boardman 56
Mountain View 55
Atlanta 52
Abidjan 51
Changsha 51
Redmond 51
Shanghai 51
Council Bluffs 50
San Francisco 50
Jiaxing 48
Auburn Hills 46
Norwalk 46
Brooklyn 44
Cambridge 44
Toronto 44
Brussels 43
Helsinki 43
Philadelphia 43
Kent 40
Da Nang 39
Pune 39
Sydney 38
Denver 35
Jinan 35
Amsterdam 34
Fremont 34
Phoenix 34
Augusta 32
Düsseldorf 32
Memphis 32
Baghdad 31
Chennai 31
Paris 31
Portland 31
Melbourne 30
Haiphong 29
Rio de Janeiro 29
Johannesburg 28
Belo Horizonte 27
Detroit 27
San Diego 27
Totale 18.206
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.661
Incidence of acute myeloid leukemia after breast cancer 384
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 365
Factors associated with mortality in bacteremic patients with haematologic malignancies 356
Fanconi anemia gene variants in therapy-related myeloid neoplasms 327
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 294
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 281
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 276
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 269
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 251
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 249
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 241
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 241
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 240
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 240
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 237
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 235
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 235
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 233
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 232
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 228
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 226
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 222
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 221
Correlation between paraproteinaemia and viral reactivation after allo-SCT 216
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 216
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 213
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 211
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 211
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Von hippel-lindau disease and erythrocytosis 209
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 207
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 205
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 202
Why methylation is not a marker predictive of response to hypomethylating agents 202
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 202
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 198
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 198
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 197
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 196
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 195
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 191
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 191
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 189
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 188
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 186
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 186
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 185
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 185
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 183
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 183
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 182
Epigenetic changes in therapy-related MDS/AML 181
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 181
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 181
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 181
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 177
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 176
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 176
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 176
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 176
Clonal evolution in therapy-related neoplasms 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 173
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Similarities and differences between therapy-related and elderly acute myeloid leukemia 171
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 171
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 171
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 171
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 170
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 170
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 169
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 169
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 167
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 166
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 165
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Primary plasma cell leukemia followed by testicular plasmacytoma 164
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 161
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 161
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 160
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 159
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 159
Totale 23.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/20222.089 219 244 35 105 138 77 54 347 86 137 283 364
2022/20234.360 520 639 331 722 311 530 223 346 508 46 118 66
2023/20242.556 104 569 88 110 149 386 124 104 102 179 356 285
2024/20254.327 322 248 396 178 442 120 147 211 674 338 666 585
2025/202610.229 1.460 329 549 876 1.672 613 1.824 601 803 685 401 416
Totale 37.586